Science & Research
Ascentage Pharma Posts 17 Clinical Updates at EHA2026
Data from Stockholm congress covers two China-approved oncology assets with implications for global development pipelin…
All 622 stories
Condition-Specific Health
Barzolvolimab Phase 2 Data Show Durable CSU Remission Off-Treatment
Celldex's anti-KIT monoclonal antibody moves the goalposts from symptom control to potential disease modification — a s…
Condition-Specific Health
Lorundrostat Linked to Heart Failure Biomarker Reductions in Proteomic Analysis
Late-breaking findings presented at the Endocrine Society Annual Meeting add cardiovascular biomarker evidence to the a…
Condition-Specific Health
Verekitug Phase 2 Data Show 80% Responder Rate in Nasal Polyp Trial
The EAACI 2026 responder analysis adds to mounting evidence for targeted biologics in upper-airway inflammatory conditi…
Ingredients & Formulation
World Blood Donor Day: Industry Backs Donation Awareness Push
The coalition push highlights growing intersections between blood health, iron status nutrition, and functional supplem…
Industry & Business
GlobeNewswire Health Files Mislabeled Release to Functional News
The submitted release covers hospital AI strategy, not functional ingredients, nutraceuticals, or dietary supplements —…
Industry & Business
Off-Topic Submission: No Functional Food Content Found
Submission appears to be a healthcare AI conference announcement unrelated to functional foods, ingredients, or nutriti…
Industry & Business
Off-Topic Submission: No Functional Ingredient or Nutraceutical Found
Submission flagged as out-of-scope. Functional News covers ingredients, formulations, clinical trials, and regulatory n…
Industry & Business
Editor's Note: This Release Falls Outside Functional News Coverage
Functional News covers functional foods, dietary supplements, nutraceuticals, and evidence-based ingredients. This rele…
Industry & Business
Off-Topic Submission: No Functional Ingredient News to Report
Submitted release covers hospital AI governance at a European health-tech conference — outside Functional News editoria…
Ingredients & Formulation
Mitapivat Phase 3 Data Highlights Anti-Hemolytic Mechanism in SCD
Pyruvate kinase activation as a therapeutic mechanism draws renewed attention as clinical-stage data surfaces at a majo…
Condition-Specific Health
Setmelanotide Phase 2 Data Show BMI, Fat Mass Gains in PWS
Six-month interim results reinforce MC4R pathway as a viable therapeutic target, with Phase 3 development now in the ra…